RecruitingNot ApplicableNCT07404852

Non-invasive Vagus Nerve Stimulation to Reduce Inflammation and Brain Injury Blood Biomarkers Following an Acute Ischemic Stroke

Neuromodulation Using Vagus Nerve Stimulation Following Ischemic Stroke as Therapeutic Adjunct 2


Sponsor

Washington University School of Medicine

Enrollment

65 participants

Start Date

Feb 23, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This is a randomized open-label, with blinded outcome pilot study to evaluate the effect on inflammatory and brain injury laboratory values and explore clinical outcomes in patients who present with ischemic strokes due to large vessel occlusions and are treated with either current accepted management, or accepted management in addition to transcutaneous auricular vagal nerve stimulation.


Eligibility

Min Age: 18 YearsMax Age: 99 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Sham transcutaneous vagal nerve stimulation and a medical device called transcutaneous auricular vagal nerve stimulation for people with acute ischemic stroke and large vessel occlusion. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 99 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEtranscutaneous auricular vagal nerve stimulation

Stimulus of the auricular branch of the vagal nerve with the transcutaneous auricular vagal nerve stimulation.

DEVICESham transcutaneous vagal nerve stimulation

Patients assigned to the controls arm will have no electricity applied to the Auricular Branch of the Vagus Nerve.


Locations(1)

Barnes-Jewish Hospital

St Louis, Missouri, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07404852


Related Trials